CE / CME
This text-based activity examines the expanding use of bispecific antibodies in relapsed/refractory multiple myeloma, including toxicity management and REMS compliance. Expert faculty also reviews key adverse event management issues, particularly CRS, ICANS, infection risk, and GPRC5D-associated on-target/off-tumor effects, and discusses evolving approaches, such as dexamethasone-first CRS management, prophylactic tocilizumab, infection prophylaxis, and outpatient or hybrid administration models. These considerations are clinically important because effective use of bispecific antibodies requires learners to balance strong antimyeloma efficacy with proactive monitoring, multidisciplinary coordination, and individualized supportive care to improve safety and expand access across academic and community practice settings.
Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit
Pharmacists: 0.50 contact hour (0.05 CEUs)
ABIM MOC: maximum of 0.50 Medical Knowledge MOC point
Physicians: maximum of 0.50 AMA PRA Category 1 Credit™
Nurse Practitioners/Nurses: 0.50 Nursing contact hour
Released: August 18, 2026
Expiration: February 17, 2027
Share
Provided by Clinical Care Options, LLC dba Decera Clinical Education
This activity is supported by an educational grant from Johnson & Johnson.
Johnson & Johnson
This activity is intended for hematologists, oncologists, emergency medicine physicians, neurologists, infectious disease specialists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals caring for patients with multiple myeloma who are eligible for or receiving bispecific antibody therapy.
The goal of this activity is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Multiple Myeloma.
Upon completion of this activity, participants should be able to:
Implement effective workflow processes to monitor and manage bispecific antibody–related toxicities in patients with MM using the latest evidence and expert-recommended strategies
Develop plans for coordinating care among different specialists, departments, and/or centers to optimize each patient’s therapeutic benefit from bispecific antibody therapy for MM
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Primary AuthorJessica McElwee, PharmD, BCOP: advisor: GSK.
The planners and content peer reviewers from Decera Clinical Education do not have any relevant financial relationships to disclose, except Carol Ann Huff, MD and Kristi K. Orbaugh, MSN, NP, AOCNP, as noted below:
Carol Ann Huff, MD: consultant/advisor/speaker: AstraZeneca, Bristol Myers Squibb, Janssen, Legend, Prothena; researcher: Janssen, Prothena.
Kristi K. Orbaugh, MSN, NP, AOCNP: speaker: AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, DSI, Exelixis, Lilly, Pfizer, Stemline.
Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 18, 2026, through February 17, 2027:
You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.
This program has been made available online.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Generative artificial intelligence (AI) tools were used for data analysis or summarization influencing content, and revising or refining educational content. All AI-assisted content underwent human review, editing, and validation by qualified faculty and accredited education staff to ensure scientific accuracy, balance, and compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education.
Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Clinical Care Options, LLC dba Decera Clinical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.
Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 0.5 contact hours (0.05 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-26-463-H01-P
Type of Activity: Application
Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until February 17, 2027. PAs should only claim credit commensurate with the extent of their participation.
American Board of Internal Medicine Maintenance of Certification 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For ABIM MOC points, your information will be shared with the ABIM through Decera Clinical Education’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
By sharing your Diplomate Board ID # and DOB, you are giving Decera Clinical Education permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).
IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.